HERBALIFE LTD. (HLF) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $128.30M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $138.40M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $125.80M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $132.60M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $128.30M | (m) | $1.33B | (m) | $11.30M* | $32.90M* | $296.30M | (m) | (m) | $22.80M |
| 2026-03-31 | Reported | (m) | $138.40M | (m) | $1.32B | (m) | $10.90M | $113.80M | $291.10M | (m) | (m) | $30.40M |
| 2025-09-30 | Reported | (m) | $125.80M | (m) | $1.27B | (m) | $20.80M* | $138.80M* | $284.20M | (m) | $447.60M | $31.70M |
| 2025-06-30 | Reported | (m) | $132.60M | (m) | $1.26B | (m) | $22.80M* | $96.00M* | $276.90M | (m) | $447.90M | $29.80M |
| 2025-03-31 | Reported | (m) | $122.80M | (m) | $1.22B | (m) | $18.30M | $200.00K | $265.20M | (m) | $431.90M | $20.40M |
| 2024-09-30 | Reported | (m) | $127.10M | (m) | $1.24B | (m) | $27.10M* | $99.50M* | $268.70M | (m) | $444.00M | $23.20M |
| 2024-06-30 | Reported | (m) | $80.40M | (m) | $1.28B | (m) | $36.30M* | $102.50M* | $283.10M | (m) | $502.30M | $7.50M |
| 2024-03-31 | Reported | (m) | $71.90M | (m) | $1.26B | (m) | $32.90M | $13.80M | $285.00M | (m) | $492.20M | $9.70M |
| 2023-09-30 | Reported | (m) | $106.70M | (m) | $1.28B | (m) | $31.10M* | $79.60M* | $303.20M | (m) | $455.30M | $26.40M |
| 2023-06-30 | Reported | (m) | $123.40M | (m) | $1.31B | (m) | $38.30M* | $135.60M* | $301.60M | (m) | $460.50M | $25.10M |
| 2023-03-31 | Reported | (m) | $70.50M | (m) | $1.25B | (m) | $30.30M | $46.20M | $298.60M | (m) | $475.90M | $1.80M |
| 2022-09-30 | Reported | (m) | $147.40M | (m) | $1.30B | (m) | $37.70M* | $69.60M* | $285.10M | (m) | $448.20M | $30.70M |
| 2022-06-30 | Reported | (m) | $155.80M | (m) | $1.39B | (m) | $34.60M* | $98.80M* | $315.80M | (m) | $470.00M | $37.60M |
| 2022-03-31 | Reported | (m) | $153.10M | (m) | $1.34B | (m) | $41.30M | $130.50M | $307.10M | (m) | $454.90M | $25.20M |
| 2021-09-30 | Reported | (m) | $189.40M | (m) | $1.43B | (m) | $36.10M* | $88.00M* | $305.20M | (m) | $486.30M | $34.30M |
| 2021-06-30 | Reported | (m) | $237.90M | (m) | $1.55B | (m) | $35.00M* | $176.80M* | $323.20M | (m) | $505.90M | $32.30M |
| 2021-03-31 | Reported | (m) | $222.50M | (m) | $1.50B | (m) | $33.40M | $110.10M | $314.30M | (m) | $506.70M | $37.60M |
| 2020-09-30 | Reported | (m) | $206.90M | (m) | $1.52B | (m) | $26.00M* | $131.10M* | $322.70M | (m) | $529.70M | $33.60M |
| 2020-06-30 | Reported | (m) | $189.70M | (m) | $1.35B | (m) | $25.20M* | $243.30M* | $272.80M | (m) | $480.80M | $45.80M |
| 2020-03-31 | Reported | (m) | $95.60M | (m) | $1.26B | (m) | $24.40M | $141.70M | $245.70M | (m) | $549.00M | $25.00M |
| 2019-09-30 | Reported | (m) | $143.60M | (m) | $1.24B | (m) | $27.80M* | $186.10M* | $243.40M | (m) | $500.10M | $31.80M |
| 2019-06-30 | Reported | (m) | $153.10M | (m) | $1.24B | (m) | $24.70M* | $76.30M* | $243.20M | (m) | $477.00M | $46.20M |
| 2019-03-31 | Reported | (m) | $163.00M | (m) | $1.17B | (m) | $27.00M | $38.50M | $241.60M | (m) | $435.40M | $39.10M |
| 2018-09-30 | Reported | (m) | $187.30M | (m) | $1.24B | (m) | $22.70M* | $164.80M* | $218.10M | (m) | $499.40M | $45.30M |
| 2018-06-30 | Reported | (m) | $191.80M | (m) | $1.29B | (m) | $17.40M* | $188.70M* | $235.40M | (m) | $510.20M | $48.40M |
| 2018-03-31 | Reported | (m) | $155.80M | (m) | $1.18B | (m) | $15.60M | $156.20M | $239.90M | (m) | $460.10M | $9.40M |
| 2017-09-30 | Reported | (m) | $119.30M | (m) | $1.09B | (m) | $22.00M* | $127.30M* | $215.40M | (m) | $445.20M | $26.40M |
| 2017-06-30 | Reported | (m) | $204.90M | (m) | $1.15B | (m) | $21.40M* | (m) | $218.80M | (m) | $443.20M | $29.40M |
| 2017-03-31 | Reported | (m) | $143.80M | (m) | $1.10B | (m) | $24.50M | (m) | $204.60M | (m) | $438.60M | $28.40M |
| 2016-09-30 | Reported | (m) | $151.50M | (m) | (m) | (m) | $25.00M* | (m) | $209.10M | (m) | $441.30M | $41.70M |
| 2016-06-30 | Reported | (m) | -$19.90M | (m) | (m) | (m) | $57.20M* | (m) | $236.30M | (m) | $676.80M | -$20.10M |
| 2016-03-31 | Reported | (m) | $168.30M | (m) | (m) | (m) | $29.70M | (m) | $213.10M | (m) | $427.10M | $47.60M |
| 2015-09-30 | Reported | (m) | $161.60M | (m) | (m) | (m) | $17.60M* | (m) | $206.90M | (m) | $433.10M | $43.90M |
| 2015-06-30 | Reported | (m) | $143.80M | (m) | (m) | (m) | $17.10M* | (m) | $229.30M | (m) | $470.50M | $37.30M |
| 2015-03-31 | Reported | (m) | $135.60M | (m) | (m) | (m) | $22.80M | (m) | $215.40M | (m) | $431.40M | $33.60M |
| 2014-09-30 | Reported | (m) | $27.60M | (m) | (m) | (m) | $34.50M* | (m) | $255.00M | (m) | $609.70M | -$13.30M |
| 2014-06-30 | Reported | (m) | $196.30M | (m) | (m) | (m) | $47.00M* | (m) | $257.20M | (m) | $461.90M | $55.40M |
| 2014-03-31 | Reported | (m) | $127.50M | (m) | (m) | (m) | $58.50M | $190.65M | $251.20M | (m) | $502.10M | $34.80M |
| 2013-09-30 | Reported | (m) | $192.14M | (m) | (m) | (m) | $35.73M* | $225.53M* | $238.41M | (m) | $409.75M | $45.46M |
| 2013-06-30 | Reported | (m) | $192.36M | (m) | (m) | (m) | $31.19M* | $213.83M* | $247.22M | (m) | $400.11M | $43.64M |
| 2013-03-31 | Reported | (m) | $168.92M | (m) | (m) | (m) | $24.86M | $137.63M | $225.98M | (m) | $364.72M | $44.67M |
| 2012-09-30 | Reported | (m) | $160.84M | (m) | (m) | (m) | $19.51M* | $142.45M* | $201.60M | (m) | $324.20M | $45.42M |
| 2012-06-30 | Reported | (m) | $186.71M | (m) | (m) | (m) | $15.03M* | $137.07M* | $203.74M | (m) | $306.31M | $51.59M |
| 2012-03-31 | Reported | (m) | $154.10M | (m) | (m) | (m) | $24.69M | $120.37M | $196.14M | (m) | $296.39M | $44.80M |
| 2011-09-30 | Reported | (m) | $151.35M | (m) | (m) | (m) | $17.09M* | $142.98M* | $175.31M | (m) | $277.72M | $42.98M |
| 2011-06-30 | Reported | (m) | $153.17M | (m) | (m) | (m) | $16.10M* | $142.68M* | $171.02M | (m) | $266.23M | $41.14M |
| 2011-03-31 | Reported | (m) | $123.40M | (m) | (m) | (m) | $28.32M | $107.97M | $162.79M | (m) | $244.53M | $32.73M |
| 2010-09-30 | Reported | (m) | $100.95M | (m) | (m) | (m) | $18.28M* | $100.49M* | $133.26M | (m) | $230.15M | $19.88M |
| 2010-06-30 | Reported | (m) | $116.36M | (m) | (m) | (m) | $12.29M* | $83.20M* | $136.56M | (m) | $211.11M | $32.03M |
| 2010-03-31 | Reported | (m) | $63.96M | (m) | (m) | (m) | $11.62M | $87.43M | $140.47M | (m) | $206.88M | $10.13M |
| 2009-09-30 | Reported | (m) | $77.83M | (m) | (m) | (m) | $14.97M* | $105.03M* | $131.78M | (m) | $195.97M | $18.90M |
| 2009-06-30 | Reported | (m) | $71.82M | (m) | (m) | (m) | (m) | (m) | $122.44M | (m) | $190.79M | $22.23M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | $481.00M | (m) | $5.04B | (m) | $80.40M | $333.30M | $1.11B | (m) | (m) | $47.30M |
| 2024-12-31 | Reported | (m) | $385.90M | (m) | $4.99B | (m) | $122.00M | $285.40M | $1.10B | (m) | $1.88B | -$84.90M |
| 2023-12-31 | Reported | (m) | $356.40M | (m) | $5.06B | (m) | $135.00M | $357.50M | $1.19B | (m) | $1.87B | $60.80M |
| 2022-12-31 | Reported | (m) | $545.20M | (m) | $5.20B | (m) | $156.40M | $352.50M | $1.17B | (m) | $1.81B | $103.50M |
| 2021-12-31 | Reported | (m) | $734.10M | (m) | $5.80B | (m) | $151.40M | $460.30M | $1.24B | (m) | $2.01B | $113.60M |
| 2020-12-31 | Reported | (m) | $640.60M | (m) | $5.54B | (m) | $112.00M | $628.60M | $1.15B | (m) | $2.08B | $143.80M |
| 2019-12-31 | Reported | (m) | $568.10M | (m) | $4.88B | (m) | $106.10M | $457.50M | $958.00M | (m) | $1.94B | $140.40M |
| 2018-12-31 | Reported | (m) | $683.10M | (m) | $4.89B | (m) | $84.00M | $648.40M | $919.30M | (m) | $1.96B | $167.60M |
| 2017-12-31 | Reported | (m) | $617.10M | (m) | $4.43B | (m) | $95.50M | $590.80M | $848.60M | (m) | $1.76B | $257.30M |
| 2016-12-31 | Reported | (m) | $458.10M | (m) | $4.49B | (m) | $143.40M | $367.30M | $854.60M | (m) | $1.97B | $104.70M |
| 2015-12-31 | Reported | (m) | $583.60M | (m) | (m) | (m) | $79.00M | (m) | $856.00M | (m) | $1.78B | $147.30M |
| 2014-12-31 | Reported | (m) | $513.50M | (m) | (m) | (m) | $173.70M | (m) | $982.90M | (m) | $1.99B | $112.60M |
| 2013-12-31 | Reported | (m) | $735.30M | (m) | (m) | (m) | $146.90M | $772.88M | $963.40M | (m) | $1.63B | $189.20M |
| 2012-12-31 | Reported | (m) | $661.40M | (m) | (m) | (m) | $121.50M | $567.78M | $812.60M | (m) | $1.26B | $186.90M |
| 2011-12-31 | Reported | (m) | $562.27M | (m) | (m) | (m) | $90.41M | $510.54M | $680.08M | (m) | $1.07B | $144.82M |
| 2010-12-31 | Reported | (m) | $387.51M | (m) | (m) | (m) | $68.13M | $387.88M | $558.81M | (m) | $887.65M | $87.21M |
| 2009-12-31 | Reported | (m) | $296.03M | (m) | (m) | (m) | $59.77M | $285.06M | $493.13M | (m) | $773.91M | $87.58M |
| 2008-12-31 | Reported | (m) | $332.25M | (m) | (m) | (m) | $88.60M | $272.99M | $458.40M | (m) | $771.85M | $97.84M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |